e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Asthma: animal models
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A novel anti-inflammatory role for thymosin beta 4 sulfoxide in a murine model of allergic asthma
A. McKay, B. P. Leung, I. B. McInnes, J. D. Young, R. D. Stevenson, N. C. Thomson, F. Y. Liew (Glasgow, United Kingdom)
Source:
Annual Congress 2002 - Asthma: animal models
Session:
Asthma: animal models
Session type:
Oral Presentation
Number:
3523
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. McKay, B. P. Leung, I. B. McInnes, J. D. Young, R. D. Stevenson, N. C. Thomson, F. Y. Liew (Glasgow, United Kingdom). A novel anti-inflammatory role for thymosin beta 4 sulfoxide in a murine model of allergic asthma. Eur Respir J 2002; 20: Suppl. 38, 3523
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Neu-164, a novel antioxidant and anti-inflammatory compound reduces lung inflammation in a murine model of allergic asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008
Effect of SMP-028, a novel anti-inflammatory agent, on experimental allergic asthma in guinea pig model
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Critical immunoregulatory role for activin-A in human allergic asthma
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Role of mouse mast cell protease 4 in a murine model of allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Anti-inflammatory and anti-asthmatic effects of resolvin E1 in a mouse model of allergic asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Neutraligands of CXCL12: Anti-inflammatory activity in an allergic model of asthma
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
IL-13-dependent C3a-release in a murine model of allergic asthma
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005
An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 28s
Year: 2002
Pharmacological characterization of the protective effect of mepolizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Effect of a pan-JAK inhibitor pyridone 6 on airway responses in murine asthma model
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Relationships between glutaredoxin 1 and cytokine levels in a murine model of allergic airway inflammation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Protective effect of thrombomodulin in a murine model of allergen-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Murine models of asthma
Source: Eur Respir J 2003; 22: 374-382
Year: 2003
Der p 2-derived peptide abrogates HDM-induced allergic asthma in mouse and humanized model
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003
The effect of anti-inflammatory treatment on bacterial rhino-sinusitis in a murine model
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002
The therapeutic efficacy of OAT-889 (dual AMCase/CHIT1 inhibitor) in comparison to montelukast in HDM-induced model of chronic airway inflammation in mice
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
Investigations on the role of region-specific IL-13 receptor alpha 1 expression along the airway tree in mucus production in asthma
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept